Changsha Rail Transit Group was established in June 2006 and restructured by the municipal authorities in April 2009. The original profile describes a wholly state-owned company with registered capital of RMB 5 billion, responsible for financing, investment, construction, operation and management of rail transit projects.
At the time of the original profile, the group comprised 18 departments, 13 wholly owned or controlled subsidiaries, one branch and one associated company under authorized management, supported by specialized operating teams.
The company's stated vision combines a respected business with employee well-being. Its values emphasize responsibility, rigor, innovation, integrity and collaboration, while its development principles focus on safe, well-built, environmentally responsible and people-centered rail transit.
BIOSUN provides air treatment solutions for rail transit. Its Chinese project profile reports experience across more than 100 rail projects in China and overseas, with applications addressing airborne microorganisms, particles, chemical gases and emissions from interior materials in occupied transport environments.
Applications cover train interiors, platforms, station halls and public restrooms. BIOSUN applies PHOTOPLASMA technology to selected microbial, gaseous and particulate air treatment requirements. Performance should be assessed against the equipment specifications, relevant test reports and operating conditions.
